Key Record Dates
ClinicalTrials.gov Identifier: | NCT03922477 |
---|---|
Brief Title: | A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia |
First Submitted : | April 11, 2019 |
First Submitted that Met QC Criteria : | April 17, 2019 |
First Posted : | April 22, 2019 |
Last Update Submitted that Met QC Criteria : | December 11, 2020 |
Last Update Posted : | December 14, 2020 |